Vaxart, Inc. Gains 28%
Mon 03 Feb 20 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) jumped higher at $1.6, representing a gain of 28%. On Fri 31 Jan 20, VXRT:NASDAQ touched a New 2-Week High of $1.25. The stock got featured on our News Catalysts scanner on Mon 03 Feb 20 at 04:18 PM in the 'BIOTECH' category. From Fri 10 Jan 20, the stock recorded 50.00% Up Days and 33.33% Green Days
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 96.46%
- Gulf Resources, Inc. (GURE:NASDAQ), 50.71%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 45.45%
- OpGen, Inc. (OPGN:NASDAQ), 44.59%
- Insmed Incorporated (INSM:NASDAQ), 40.6%
- Four Seasons Education (Cayman) Inc. (FEDU:NYSE), 28.46%
- Shineco, Inc. (TYHT:NASDAQ), 28.07%
- Vaxart, Inc. (VXRT:NASDAQ), 28%
- AIM ImmunoTech Inc. (AIM:NYSEMKT), 25.14%
- BIO-key International, Inc. (BKYI:NASDAQ), 22.7%